Detailed information for compound 278801

Basic information

Technical information
  • TDR Targets ID: 278801
  • Name: propyl 5-ethylsulfanylcarbonyl-6-(2-hydroxyet hyl)-2-phenyl-4-propylpyridine-3-carboxylate
  • MW: 415.546 | Formula: C23H29NO4S
  • H donors: 1 H acceptors: 4 LogP: 4.97 Rotable bonds: 12
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCOC(=O)c1c(CCC)c(C(=O)SCC)c(nc1c1ccccc1)CCO
  • InChi: 1S/C23H29NO4S/c1-4-10-17-19(23(27)29-6-3)18(13-14-25)24-21(16-11-8-7-9-12-16)20(17)22(26)28-15-5-2/h7-9,11-12,25H,4-6,10,13-15H2,1-3H3
  • InChiKey: FVJPNUKHDFVHPJ-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • propyl 5-ethylsulfanylcarbonyl-6-(2-hydroxyethyl)-2-phenyl-4-propyl-pyridine-3-carboxylate
  • 5-[(ethylthio)-oxomethyl]-6-(2-hydroxyethyl)-2-phenyl-4-propyl-3-pyridinecarboxylic acid propyl ester
  • 5-(ethylthio)carbonyl-6-(2-hydroxyethyl)-2-phenyl-4-propyl-nicotin propyl ester
  • 5-(ethylthio)carbonyl-6-(2-hydroxyethyl)-2-phenyl-4-propyl-nicotinic acid propyl ester

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Adenosine A1 receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Onchocerca volvulus Ubiquinol-cytochrome-c reductase complex assembly factor 1 homolog Adenosine A1 receptor   326 aa 286 aa 22.7 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 323 aa 20.7 %
Schistosoma mansoni peptide (allatostatin)-like receptor Adenosine A1 receptor   326 aa 327 aa 24.8 %
Brugia malayi hypothetical protein Adenosine A1 receptor   326 aa 305 aa 21.0 %
Echinococcus multilocularis allatostatin A receptor Adenosine A1 receptor   326 aa 303 aa 24.1 %
Echinococcus granulosus allatostatin A receptor Adenosine A1 receptor   326 aa 303 aa 24.1 %
Schistosoma mansoni neuropeptide receptor Adenosine A1 receptor   326 aa 274 aa 22.6 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 304 aa 21.1 %
Schistosoma japonicum Alpha-1A adrenergic receptor, putative Adenosine A1 receptor   326 aa 295 aa 28.1 %
Schistosoma japonicum 5-hydroxytryptamine receptor 4, putative Adenosine A1 receptor   326 aa 286 aa 26.9 %
Echinococcus granulosus thyrotropin releasing hormone receptor Adenosine A1 receptor   326 aa 321 aa 23.1 %
Schistosoma mansoni dro/myosuppressin receptor Adenosine A1 receptor   326 aa 326 aa 22.1 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Adenosine A1 receptor   326 aa 315 aa 21.6 %
Echinococcus multilocularis neuropeptide receptor Adenosine A1 receptor   326 aa 299 aa 22.4 %
Loa Loa (eye worm) neuropeptide F receptor Adenosine A1 receptor   326 aa 316 aa 19.9 %
Loa Loa (eye worm) hypothetical protein Adenosine A1 receptor   326 aa 300 aa 24.3 %
Schistosoma japonicum ko:K04134 cholinergic receptor, invertebrate, putative Adenosine A1 receptor   326 aa 317 aa 24.6 %
Onchocerca volvulus Adenosine A1 receptor   326 aa 306 aa 21.2 %
Schistosoma mansoni neuropeptide receptor Adenosine A1 receptor   326 aa 311 aa 21.2 %
Echinococcus granulosus neuropeptide receptor Adenosine A1 receptor   326 aa 299 aa 22.4 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Adenosine A1 receptor   326 aa 321 aa 22.7 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Mycobacterium leprae DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) 0.7865 1 1
Loa Loa (eye worm) dihydrofolate reductase 0.7865 1 1
Brugia malayi Dihydrofolate reductase 0.7865 1 1
Echinococcus multilocularis dihydrofolate reductase 0.7865 1 1
Schistosoma mansoni dihydrofolate reductase 0.7865 1 1
Toxoplasma gondii bifunctional dihydrofolate reductase-thymidylate synthase 0.3922 0.4469 0.5
Trypanosoma cruzi dihydrofolate reductase-thymidylate synthase 0.3922 0.4469 0.5
Onchocerca volvulus 0.0736 0 0.5
Chlamydia trachomatis dihydrofolate reductase 0.7865 1 0.5
Trypanosoma brucei dihydrofolate reductase-thymidylate synthase 0.3922 0.4469 0.5
Mycobacterium tuberculosis Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) 0.7865 1 1
Plasmodium vivax bifunctional dihydrofolate reductase-thymidylate synthase, putative 0.3922 0.4469 0.5
Echinococcus granulosus dihydrofolate reductase 0.7865 1 1
Mycobacterium ulcerans dihydrofolate reductase DfrA 0.7865 1 1
Leishmania major dihydrofolate reductase-thymidylate synthase 0.3922 0.4469 0.5
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase 0.3922 0.4469 0.5

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 16 % Displacement of specific [125 I]AB-MECA binding at human Adenosine A3 receptor expressed in HEK cells ChEMBL. 10052977
Inhibition (binding) = 16 % Displacement of specific [125 I]AB-MECA binding at human Adenosine A3 receptor expressed in HEK cells ChEMBL. 10052977
Ki (binding) = 5940 nM Displacement of specific [3H]-CGS- 21680R-PIA binding to Adenosine A1 receptor in rat brain membranes. ChEMBL. 10052977
Ki (binding) = 5940 nM Displacement of specific [3H]-CGS- 21680R-PIA binding to Adenosine A1 receptor in rat brain membranes. ChEMBL. 10052977
Ki (binding) = 29100 nM Inhibition of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes. ChEMBL. 10052977
Ki (binding) = 29100 nM Inhibition of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes. ChEMBL. 10052977

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.